United States · FDA National Drug Code directory

Adrenapar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44911-0037_122799c5-9bc4-49ca-8935-f31d0db3dbee
Product NDC
44911-0037
Form
LIQUID
Composition / generic term
Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Zincum Metallicum
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20121004 / 20270113

Source-listed ingredients

  • AMERICAN GINSENG — 3 [hp_X]/mL
  • AVENA SATIVA FLOWERING TOP — 3 [hp_X]/mL
  • SUS SCROFA ADRENAL GLAND — 6 [hp_X]/mL
  • ARSENIC TRIIODIDE — 12 [hp_X]/mL
  • STRYCHNOS IGNATII SEED — 12 [hp_X]/mL
  • LYCOPODIUM CLAVATUM SPORE — 12 [hp_X]/mL
  • STRYCHNOS NUX-VOMICA SEED — 12 [hp_X]/mL
  • PHOSPHORIC ACID — 12 [hp_X]/mL
  • PHOSPHORUS — 12 [hp_X]/mL
  • ZINC — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 mL in 1 BOTTLE, DROPPER (44911-0037-1) · 44911-0037-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →